RegisterPROS - a Registry for Prostate Cancers
The RegisterPROS study is building a confidential registry of men who have prostate cancer. Researchers want to gather information and blood samples from patients to learn more about the disease. They are especially interested in new, simpler blood tests, such as one called PROSTest, that might help doctors diagnose prostate cancer earlier, track its progress, and see if treatments are working. By collecting this information, the study hopes to improve how prostate cancer is detected, monitored, and treated in the future, ultimately leading to better care for patients. All data is kept private.
A colpo d'occhio
Di cosa tratta questo studio?
Prostate cancer starts in a small gland in men called the prostate. There are many ways to treat it, including surgery, medicines, and radiation. Doctors know that finding prostate cancer early and accurately, or catching when it comes back or treatments stop working, can make a big difference in how well men do.
Currently, there are tests like PSA (Prostate-Specific Antigen) that help, but doctors are always looking for even better ways to check for prostate cancer without needing invasive procedures. They also want to understand if certain tests can help predict which treatments will work best for individual patients.
That's where the RegisterPROS study comes in. It's collecting information and blood samples from men with prostate cancer from different places like Europe, Africa, the Caribbean, and the USA. The aim is to build a large database to study how good new blood tests, like one called PROSTest, are at finding prostate cancer and tracking it over time. The study will also look at how different treatments work and what happens with the disease, to give doctors more information to help their patients.
Punti chiave
- RegisterPROS is building a database about prostate cancer.
- It aims to improve diagnosis and monitoring using new blood tests like PROSTest.
- The study collects anonymised data and samples from men with prostate cancer.
- It could lead to better future treatments and understanding of the disease.
- Participation involves sharing medical information and providing blood/saliva samples.
- Your personal information will be kept private.
Chi può essere idoneo?
This study is looking for men who have been diagnosed with prostate cancer. You would need to have had a biopsy that confirmed you have the disease.
Generally, participants should be between 45 and 100 years old. The study is open to all men who fit the diagnosis criteria within this age range.
Questo studio potrebbe fare al caso tuo?
Rispondi a queste domande rapide per vedere se potresti essere idoneo. Questo è solo una guida — il team di ricerca prende la decisione finale.
- I am a male.
- I have been diagnosed with prostate cancer.
- My prostate cancer diagnosis was confirmed with a biopsy.
- I am between 45 and 100 years old.
Cosa comporta la partecipazione?
If you decide to take part in RegisterPROS, your doctor will collect some information about your health and your prostate cancer. They will also take blood and saliva samples from you. This information and your samples will be sent to the study in a way that keeps your identity private. The study will then follow your progress over time, checking how your condition is doing and how well any treatments are working. You and your doctor would decide how long you participate, as this depends on your ongoing care, but your data would be regularly evaluated within the study.
Rischi e benefici potenziali
Luoghi (1)
- University Hospital MunsterCodice postale verificatoMünster, Germania
Domande comuni
What is the main goal of the RegisterPROS study?
The main goal is to create a large database of information and samples from men with prostate cancer to find better ways to diagnose and monitor the disease, especially with new simple blood tests.
What is PROSTest?
PROSTest is an example of a new type of blood test that the study is looking at to see if it can help doctors detect and track prostate cancer more effectively than current methods.
I miei dati personali saranno mantenuti privati?
Yes, all data collected for the study will be anonymised, meaning your name and other identifying information will be removed to protect your privacy.
Do I have to change my prostate cancer treatment if I join?
No, joining this registry will not require you to change your existing prostate cancer treatment plan. Your doctors will continue to manage your care as usual.
Per quanto tempo sarò coinvolto nello studio?
Your involvement typically aligns with your ongoing medical appointments for prostate cancer. Information will be collected regularly, but you can discuss the exact duration with your doctor.
Come saperne di più
Parla sempre con il tuo medico di base o specialista prima di decidere di partecipare a uno studio.
Interessato a partecipare?
Discussione
Discussione della comunità
Supportato dal nostro forum su community.patient.info. Si prega di essere rispettosi — questo non è un consiglio medico.